Most wealthy physicians follow three key paths:
Each of these doctors combined medical expertise with business acumen to create lasting wealth.
When you hear the phrase richest doctor, most people picture a surgeon with a golden stethoscope. In reality, the title belongs to a biotech mogul who turned a cancer‑research breakthrough into a multi‑billion‑dollar empire. This article uncovers who holds the crown in 2025, how that fortune was built, and who trails closely behind.
Dr. Patrick Soon-Shiong is a South‑African‑born surgeon, scientist, and serial entrepreneur who tops the list of wealthiest physicians. According to the latest Forbes billionaire tracker, his net worth sits at approximately $15billion. He earned the nickname “the billionaire doctor” after founding Nirvana Oncology and later Nuvance Health, which merged several hospitals and generated billions in revenue.
Besides his medical practice, Dr. Soon-Shiong’s wealth flows from a portfolio of biotech patents, the acquisition of pharmaceutical companies, and a strategic investment in the media industry-most notably the purchase of the LosAngeles Times and the SanDiego Union‑Tribune in 2018.
Most doctor‑billionaires share three common pathways:
These routes require not just medical expertise but also a solid grasp of business strategy, market timing, and a willingness to take calculated risks.
Below is a snapshot of the five most affluent physicians beside Dr. Soon‑Shiong. Figures stem from the 2025 Forbes list, Bloomberg estimates, and public financial disclosures.
Rank | Doctor | Net Worth (USD) | Primary Source of Wealth | Flagship Company |
---|---|---|---|---|
1 | Patrick Soon-Shiong | $15billion | Biotech & media holdings | Nuvance Health / NantWorks |
2 | ThomasFristJr. | $5.5billion | Hospital chain ownership | HCA Healthcare |
3 | GaryMichelson | $3.2billion | Orthopedic implant patents | Michelson Foundry |
4 | RobertLanger | $1.9billion | Drug delivery systems | Moderna (early investor) |
5 | LeonardLiu | $1.5billion | Genomics & precision medicine | Foundation Medicine |
Dr. ThomasFristJr. co‑founded HCA Healthcare in 1968, which grew into the largest for‑profit hospital operator in the United States. After selling a large share of the company in the 1990s, he diversified into private equity, real estate, and venture capital, keeping his net worth well over $5billion.
Dr. GaryMichelson made his fortune by inventing a revolutionary spinal implant and licensing it to major medical device manufacturers. He later sold his stake for $1billion and turned to philanthropy, creating the Michelson Medical Research Foundation.
Dr. RobertLanger, a MIT professor, holds more than 1,400 patents related to drug delivery and tissue engineering. His early investment in Moderna's mRNA platform earned him a hefty return when the company’s COVID‑19 vaccine skyrocketed.
Dr. LeonardLiu built his wealth through precision‑oncology startups, most notably the acquisition of Foundation Medicine by Roche. His strategic stake in genomics data platforms keeps his net worth climbing.
While each story is unique, a few patterns emerge:
Massive fortunes raise eyebrows. Critics argue that doctor‑entrepreneurs can create conflicts of interest, especially when they own stakes in products they prescribe. For instance, Dr. Michelson faced scrutiny for lobbying doctors to use his patented spinal devices. Dr. Soon‑Shiong’s media purchases sparked debate over potential influence on public health reporting.
Transparency is key. The medical community now encourages physicians to disclose financial interests in peer‑reviewed journals and during clinical trials to mitigate bias.
If you’re a doctor dreaming of a biotech startup, the playbook is clear:
Following these steps doesn’t guarantee billionaire status, but it aligns your medical expertise with proven wealth‑creation pathways.
As of 2025, Dr. Patrick Soon‑Shiong holds the title with an estimated net worth of about $15billion, driven by his biotech ventures and media holdings.
Analysts combine public stock holdings, private company valuations, real‑estate assets, and disclosed earnings. They cross‑reference SEC filings, Forbes billionaire rankings, and reputable financial news sources.
It’s rare but possible. Most billionaire doctors build their fortunes through parallel entrepreneurial ventures, often reducing direct patient care to focus on business development.
Conflicts of interest can influence prescribing habits, research outcomes, and policy advocacy. Transparency, mandatory disclosures, and independent oversight help mitigate these risks.
Biotech founders often come from surgical, oncology, and pharmacology backgrounds. Orthopedic innovators (e.g., Dr. Michelson) and pharmaceutical researchers (e.g., Dr. Langer) also rank high.